ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Up After Analyst Upgrade
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) gapped up before the market opened on Tuesday after Oppenheimer raised their price target on the stock from $39.00 to $44.00. The stock had previously closed at $22.80, but opened at $24.03. Oppenheimer currently has an outperform rating on the stock. ArriVent BioPharma shares last traded at […]
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) gapped up before the market opened on Tuesday after Oppenheimer raised their price target on the stock from $39.00 to $44.00. The stock had previously closed at $22.80, but opened at $24.03. Oppenheimer currently has an outperform rating on the stock. ArriVent BioPharma shares last traded at […]
